Seres Therapeutics
Price & Volume
Stats
See more52W Range | $4.31-$29.98 |
Market Cap | $50.2M |
Shares Short | 367,864 |
Financials
See moreRevenue (12 Mos) | $1.8M |
Revenue Growth (YoY) | -93.4% |
Gross Profit (12 Mos) | -$46M |
Diluted EPS | -$2.59 |
News
See moreYahoo Finance • 24 days ago
Seres Therapeutics EPS of $0.47, revenue of $0.74M beats by $0.56M
Yahoo Finance • 3 months ago
Seres Therapeutics Announces Two Transactions to Strengthen Balance Sheet, Reduce On-Going Lease Costs and Extend Projected Operating Cash Runway Well Into the First Quarter of 2027
Yahoo Finance • 4 months ago
Seres Therapeutics to Participate in H.C. Wainwright 4th Annual BioConnect Investor Conference
Yahoo Finance • 6 months ago
Sector Update: Health Care Stocks Rise Late Afternoon
About
CEO | Mr. Richard N. Kender B.S., M.B.A. |
CFO | Ms. Marella Thorell CPA |
Address | 101 Cambridgepark Drive, Cambridge, MA, United States, 02140 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 66 |